Trial intelligence / Profile preview

Lianhuaqingke Tablets in children with acute bronchitis (phlegm-heat obstructing lung syndrome)

ChiCTR2100052112Phase 4Not yet recruiting

Sponsor
Hebei Provincial Hospital of Traditional Chinese Medicine
Start
Oct 2021
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Lianhua Qingke in acute bronchitis (2 arms), sponsored by Hebei Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Median time to disease recovery. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

Lianhua Qingke
03

Conditions

acute bronchitis

Beyond the preview

Go deeper on ChiCTR2100052112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call